XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Dow closes at another record high as chip stocks, retail data support



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Dow closes at another record high as chip stocks, retail data support</title></head><body>

Dow ends at record peak for fourth session in five

TSMC gains after forecasting Q4 revenue jump

Travelers, Blackstone at record closes after Q3 profit beats

Elevance Health biggest dip in 4.5 years on profit forecast cut

Indexes: Dow up 0.37%, S&P 500 down 0.02%, Nasdaq up 0.04%

Adds closing prices

By David French

Oct 17 (Reuters) -The Dow Jones Industrial Average advanced onThursday to its fourth record close in the last five sessions, as stronger-than-expected monthly retail sales indicated a robust U.S. consumer and TSMC's upbeat forecast buoyed chipmakers' stocks.

Theother main Wall Street benchmarks were largely unchanged, as theS&P 500 dipped to a fractional loss andthe Nasdaq Composite eked out a tiny win.

Taiwan Semiconductor Manufacturing Co 2330.TW, the world's largest contract chipmaker, beat market estimates for profit and forecast a jump in fourth-quarter revenue, driven by demand for artificial intelligence chips.

The chipmaker's U.S.-listed shares TSM.N soared 9.8%, while artificial intelligence-trade favorite and TSMC customer Nvidia NVDA.O gained 0.9%.

The optimism spread to other chip stocks, sending the broader Philadelphia SE Semiconductor index .SOX 1% higher.

Fresh U.S. data confirmed healthy growth in the world's largest economy, while keeping bets on a 25-basis-point rate cut at the Federal Reserve's next meeting largely intact at 89.4%, according to CME's FedWatch.

U.S. retail sales increased 0.4% in September, slightly more than expected, while weekly jobless claims fell unexpectedly.

A broadly upbeat start to the third-quarter earnings season, strong economic data and the Fed kicking off its policy-easing cycle have pushed the Dow and the S&P 500 to record highs in recent sessions, with the latter close to the psychologically important 6,000 mark.

The S&P 500 .SPX lost 1.00 points, or 0.02%, at 5,841.47 points, while the Nasdaq Composite .IXIC climbed 6.53 points, or 0.04%, to 18,373.61. The Dow Jones Industrial Average .DJI rose 161.35 points, or 0.37%, to 43,239.05.

Josh Jamner, investment strategy analyst at ClearBridge Investments, said investors have been revising economic and earnings growth expectations as robust data eased worries about a recession.

However, investors were trying to figure out which companies and sectors will lead the market higher, and when to rotate into them, after months of megacap stocks driving market rallies.

"Overall, it's allowing the market to advance, but maybe in a somewhat more restrained fashion than what otherwise might be expected," Jamner said.

While theDow advanced for the second straight day, small cap indexes fell. The Russell 2000 .RUT dipped 0.3% andthe S&P Small Cap 600 .SPCY slipped 0.2%, a day after closingat their highest in nearly three years.

A majority of S&P 500 sectors were also weaker, including rate-sensitive indexes such as utilities .SPLRCU and real estate <.SPLRCR>, which slipped 0.9% and 0.7%, respectively.

One other quirk is that U.S. equity benchmarks have advanced in recent days even as U.S. Treasury yields have crept up. On Thursday, the benchmark 10-year note yield US10YT=TWEB rose 7.5 basis points to 4.091%.

In earnings-related moves, Travelers Companies TRV.N and Blackstone Group BX.N advanced 9% and 6.3%, respectively, to record closing highs after both the insurer and the money manager posted third-quarter profit which beat market expectations.

The S&P Banks index .SPXBK edged up 0.1%, advancing for afifth straight session, matching its mid-August run and just one off its six successive wins in April, as a slew of larger regional banks posted third-quarter numbers. M&T Bank MTB.N and Synovus Financial SNV.N rose more than 5%, but Truist Financial TFC.N dropped 3.5% and Huntington Bancshares<HBAN.O> slipped 2.6%.

Outside financials, health insurer Elevance Health ELV.N plummeted 10.6%, its biggest one-day drop since the start of the pandemic in March 2020, afterslashing its full-year profit forecast.

Volume on U.S. exchanges was 11.34 billion shares, compared with the 12.08 billion average for the full session over the last 20 trading days.



Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru and David French in New York; Editing by Pooja Desai and Richard Chang

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques